Trisalus Life Sciences Stock Current Valuation
| TLSI Stock | 4.93 0.12 2.38% |
Valuation analysis of TriSalus Life Sciences helps investors to measure TriSalus Life's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that TriSalus Life's price fluctuation is moderately volatile at this time. Calculation of the real value of TriSalus Life Sciences is based on 3 months time horizon. Increasing TriSalus Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since TriSalus Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TriSalus Stock. However, TriSalus Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.93 | Real 6.29 | Hype 4.92 | Naive 5.7 |
The intrinsic value of TriSalus Life's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence TriSalus Life's stock price.
Estimating the potential upside or downside of TriSalus Life Sciences helps investors to forecast how TriSalus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TriSalus Life more accurately as focusing exclusively on TriSalus Life's fundamentals will not take into account other important factors: TriSalus Life Sciences Company Current Valuation Analysis
TriSalus Life's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current TriSalus Life Current Valuation | 259 M |
Most of TriSalus Life's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TriSalus Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, TriSalus Life Sciences has a Current Valuation of 259 M. This is 98.2% lower than that of the Health Care Equipment & Supplies sector and 97.92% lower than that of the Health Care industry. The current valuation for all United States stocks is 98.44% higher than that of the company.
TriSalus Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TriSalus Life's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TriSalus Life could also be used in its relative valuation, which is a method of valuing TriSalus Life by comparing valuation metrics of similar companies.TriSalus Life is currently under evaluation in current valuation category among its peers.
TriSalus Fundamentals
| Return On Equity | -4.96 | ||||
| Return On Asset | -0.53 | ||||
| Profit Margin | (0.87) % | ||||
| Operating Margin | (0.65) % | ||||
| Current Valuation | 259 M | ||||
| Shares Outstanding | 49.87 M | ||||
| Shares Owned By Insiders | 40.92 % | ||||
| Shares Owned By Institutions | 17.20 % | ||||
| Number Of Shares Shorted | 582.93 K | ||||
| Price To Book | 30.29 X | ||||
| Price To Sales | 7.00 X | ||||
| Revenue | 29.43 M | ||||
| Gross Profit | 30.47 M | ||||
| EBITDA | (36.16 M) | ||||
| Net Income | (30.05 M) | ||||
| Total Debt | 23.63 M | ||||
| Book Value Per Share | (0.51) X | ||||
| Cash Flow From Operations | (40.84 M) | ||||
| Short Ratio | 12.44 X | ||||
| Earnings Per Share | (1.15) X | ||||
| Target Price | 11.31 | ||||
| Number Of Employees | 110 | ||||
| Beta | 0.48 | ||||
| Market Capitalization | 251.83 M | ||||
| Total Asset | 23.97 M | ||||
| Retained Earnings | (279.55 M) | ||||
| Working Capital | 10.44 M | ||||
| Net Asset | 23.97 M |
About TriSalus Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TriSalus Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TriSalus Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TriSalus Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether TriSalus Life Sciences is a strong investment it is important to analyze TriSalus Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TriSalus Life's future performance. For an informed investment choice regarding TriSalus Stock, refer to the following important reports:Check out TriSalus Life Piotroski F Score and TriSalus Life Altman Z Score analysis. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TriSalus Life. If investors know TriSalus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TriSalus Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TriSalus Life Sciences is measured differently than its book value, which is the value of TriSalus that is recorded on the company's balance sheet. Investors also form their own opinion of TriSalus Life's value that differs from its market value or its book value, called intrinsic value, which is TriSalus Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TriSalus Life's market value can be influenced by many factors that don't directly affect TriSalus Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TriSalus Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if TriSalus Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TriSalus Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.